TCL Archive In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine November 23, 1979
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner October 23, 1998
TCL Archive Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed April 22, 1977